ID: MRFR/F-B & N/9105-HCR | 90 Pages | Published By Snehal Singh on March 2023
Fish Protein Hydrolysate Market Size was valued at USD 0.4 billion in 2022. The Fish Protein Hydrolysate market is projected to grow from USD 0.417328 Billion in 2023 to USD 0.538248366 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.33% during the forecast period (2023 - 2030). The rising surge in health consciousness among people in the wake of the rising prominence of sedentary working conditions in conjunction with a stressful and hectic lifestyle are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Fish Protein Hydrolysate Market Trends
Wheat products can cause someone to develop a wheat allergy. When the body creates antibodies for proteins found in wheat, it develops a wheat allergy. If a person develops a wheat allergy, exposure to wheat proteins will trigger an allergic reaction in the immune system. It is possible to develop an allergy to any one of the four groups of wheat proteins, including gliadin, albumin, globulin, and gluten. Celiac disease is brought on by an inappropriate immune response to a particular protein in wheat called gluten. Humans who are allergic to wheat may experience various problems, such as tightness in the chest, significant difficulty breathing, nasal congestion, difficulty swallowing, and more. Fish protein hydrolysate has a lot of room to grow, given the many difficulties brought on by allergies to wheat proteins and the growing consumer awareness of these allergies.
Fish protein hydrolysate is used by people suffering from gluten intolerance, celiac disease, and milk allergy. Celiac disease affects nearly 1% of the global population. In contrast, gluten sensitivity is more common than celiac disease and affects 20 million people in the United States alone, 6% to 7% of the total population. These factors have recently enhanced the Fish Protein Hydrolysate market CAGR globally.
The acid hydrolysis technology dominated the hydrolysate market and generated the highest revenue in 2020, owing to its widespread use. The increasing product market demand as a gelling agent, binder, and emulsifier, for various use in the food and beverage industry, such as functional foods and nutritional supplements, is anticipated to augment Fish Protein Hydrolysate market revenue.
Fish Protein Hydrolysate Market Segment Insights
Fish Protein Hydrolysate Source Insights
Based on Source, the Fish Protein Hydrolysate Market segmentation includes Anchovy, Herrings, Menhaden, Sardines, and Shads. The Anchovy Fish Protein Hydrolysate segment held the majority share in 2022contribution to around in respect to the Fish Protein Hydrolysate Market revenue. The fish protein hydrolysate made from anchovies is incredibly nutrient-rich. The excellent production and high content of amino acids in the product are credited with driving the growth of the anchovies market. Trypsin, cathepsin, and other endogenous substances like chymotrypsin, which aid in the hydrolysis of proteins, are typically present in anchovies. The anchovy section of the fish protein hydrolysate market has more prospects since anchovies have cancer-prevention capabilities that make them suitable for use in nutritious food products.
February 2022: Walking Fish Therapeutics, a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising $73 million. The additional investment, co-led by Northpond Ventures and First Spark Ventures, with support from Terra Magnum Capital Partners, will be used to advance a pipeline of B cell therapeutics for oncology, rare disease, regenerative medicine, autoimmune disease, and recombinant antibody production. Walking Fish's platform for protein factories and oncology applications has continued to demonstrate positive preclinical data across multiple indications. The additional proceeds will accelerate platform development and establish Walking Fish as the leader in the rapidly emerging B-cell therapeutics field.
January 2020: BlueNalu, California, seafood products manufacturing company, announced a partnership with Nutreco, an aquafeed manufacturing company. This partnership will help BlueNalu to straighten its position in the seafood manufacturing market.
Figure 1: Fish Protein Hydrolysate Market, by Source, 2022& 2030(USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Fish Protein Hydrolysate By Form Insights
Based on form, the Fish Protein Hydrolysate Market segmentation includes Liquid, Powder. The Powder segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The powder form is an amorphous, spray-dried, and free-flowing substance containing many proteins. The growth of this market is because of its numerous applications in industrial fermentation, fertilizer, and vet feed for piglets, poultry, fur-bearing animals, aquafeed, and the pet food trade. The powder form of a fish protein hydrolysate is quickly soluble in water, off-white in color, and low in fat. Powder form has low production costs associated with energy consumption, operation, and labor, supporting market growth.
Hence, the demand for fish protein hydrolysate in powder form is more than in liquid form owing to the ease of transportation, a longer shelf-life, and easy storage. The raw material cost is also less, as it is a by-product of Fish; this helps fuel the growth of powdered fish protein hydrolysate. Owing to the numerous benefits provided by the powder form of a fish protein hydrolysate, the market for powder form has the largest market share. It is expected to be the same for the forecast period.
Fish Protein Hydrolysate Application Insights
The Fish Protein Hydrolysate Market data has been bifurcated by Application into minimal Food, Pharmaceuticals, Animal Feed & Pet food, and Personal Care. Food accounted for the largest fish protein hydrolysate market share in the application segment. The growing number of transferrable diseases in livestock such as cattle, beef, and cows has increased the incorporation of additional additives in animal feed products to improve feed utilization and immune response and enhance the beneficial microflora, developing pathogen resistance. This has helped grow the fish protein hydrolysate market in the animal feed and pet food industry. Moreover, the strict regulatory actions regarding antibiotics being banned as feed additives because of their ill effects on animals and humans have driven the demand for natural growth promoters such as amino acids, vitamins, probiotics, enzymes, and antioxidants will help in boosting the market growth. Additionally, the increasing demand for health-benefiting food products and enhancing the protein content in their pets' diets the owners have further fueled fish protein hydrolysate demand. It also helps enhance feed efficiency, improving milk, egg, and meat yield and quality for human consumption, boosting the Fish Protein Hydrolysate industry.
December 2017: Cooke Inc, a seafood company, acquired Omega Protein Corporation, a Houston-based company, to help the expanded supply side of the company's business and also help in supporting the strategy of growth as a leader in seafood production.
Fish Protein Hydrolysate Regional Insights
By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Fish Protein Hydrolysate market accounted for USD 0.4 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the growing surge in health consciousness among people due to the rising prominence of sedentary working conditions in conjunction with a stressful and hectic lifestyle across the Region.
Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: GLOBAL FISH PROTEIN HYDROLYSATEMARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe Fish Protein Hydrolysate market accounts for the second-largest market share due to the Rising surge in health consciousness among people due to the rising prominence of sedentary working conditions in conjunction with a stressful and hectic lifestyle. Further, the Germany Fish Protein Hydrolysate market held the largest market share, and the UK Fish Protein Hydrolysate market was the fastest-growing market in the European Region.
The Asia-Pacific Fish Protein Hydrolysate Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to Consumers increasingly adopting a healthy lifestyle and inclining towards health-benefiting products. Also, the awareness of the numerous health benefits of fish protein is increasing among consumers, encouraging manufacturers to focus on using fish protein hydrolysate in various products. Moreover, the China Fish Protein Hydrolysate market held the largest market share, and the India Fish Protein Hydrolysate market was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2022–2030.
Fish Protein Hydrolysate Key Market Players& Competitive Insights
Major market players are spending a lot on R&D to increase their product lines, which will help the Fish Protein Hydrolysate market grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Fish Protein Hydrolysate industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies manufacturers adopt in the global Fish Protein Hydrolysate industry to benefit clients and expand the market sector is manufacturing locally to reduce operating costs. In recent years, the Fish Protein Hydrolysate industry has provided medicine with some of the most significant benefits. The Fish Protein Hydrolysate markets major players such as Medtronic Inc (Ireland), Abbott Laboratories (US), Stryker Corporation (US), and others are working on expanding the market demand by investing in research and development activities.
Walking Fish has created a broad B-cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and deeply understands B cell biology.
Walking Fish Therapeutics, a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising $73 million. The additional investment, co-led by Northpond Ventures and First Spark Ventures, with support from Terra Magnum Capital Partners, will be used to advance a pipeline of B cell therapeutics for oncology, rare disease, regenerative medicine, autoimmune disease, and recombinant antibody production. Walking Fish's platform for protein factories and oncology applications has continued to demonstrate positive preclinical data across multiple indications. The additional proceeds will accelerate platform development and establish Walking Fish as the leader in the rapidly emerging B-cell therapeutics field.
Cooke Inc, a global seafood leader, is driven by an innovative team that delivers superior products, service, and value to our customers safely and environmentally sustainable. The Cooke family of companies includes global aquaculture divisions under Cooke Inc.
Cooke Inc, a seafood company, acquired Omega Protein Corporation, a Houston-based company, to help the expanded supply side of the company's business and also help in supporting the strategy of growth as a leader in seafood production.
Key Companies in the Fish Protein Hydrolysate market include
Fish Protein Hydrolysate Industry Developments
January 2020: BlueNalu, California, seafood products manufacturing company, announced a partnership with Nutreco, an aquafeed manufacturing company. This partnership will help BlueNalu to straighten its position in the seafood manufacturing market.
December 2017: Cooke Inc, a seafood company, acquired Omega Protein Corporation, a Houston-based company, to help the expanded supply side of the company's business and also help in supporting the strategy of growth as a leader in seafood production.
Fish Protein Hydrolysate Market Segmentation
Fish Protein Hydrolysate Source Outlook
Fish Protein Hydrolysate Form Outlook
Fish Protein Hydrolysate Application Outlook
Fish Protein Hydrolysate Regional Outlook
Report Attribute/Metric | Details |
Market Size2022 | USD 0.4 billion |
Market Size 2023 | USD 0.417328 billion |
Market Size 2030 | USD 0.53824 billion |
Compound Annual Growth Rate (CAGR) | 4.33% (2023-2030) |
Base Year | 2022 |
Market Forecast Period | 2023-2030 |
Historical Data | 2019- 2021 |
Market Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Source, Form, Application, and Region |
Geographies Covered | North America, Europe, AsiaPacific, and the Rest of the World |
Countries Covered | The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Hofseth BioCare ASA (Norway), Diana Group (Brittany), Bio-marine Ingredients Ireland (Ireland), Copalis (France), Janatha Fish Meal & Oil Products (India), Scanbio Marine Group AS (Norway), Sopropêche (France), Omega Protein Corporation (US), Sociedad Pesquera Landes Sa (Chile), TC Union Agrotech, and United Fisheries (Thailand) |
Key Market Opportunities | · Growing side effects and allergies related to wheat protein |
Key Market Dynamics | · Growing consumer inclination toward health-benefiting products |
The Fish Protein Hydrolysate Market size was valued at USD 0.4 Billion in 2022.
The global market is projected to grow at a CAGR of 4.33% during the forecast period 2022-2030.
North America had the largest share of the global market
The key players in the market are Hofseth BioCare ASA (Norway), Diana Group (Brittany), Bio-marine Ingredients Ireland (Ireland), Copalis (France), Janatha Fish Meal & Oil Products (India), Scanbio Marine Group AS (Norway), Sopropêche (France), Omega Protein Corporation (US), Sociedad Pesquera Landes Sa (Chile), TC Union Agrotech, and United Fisheries (Thailand).
The Anchovy Fish Protein Hydrolysate category dominated the market in 2022.
Food had the largest share of the global market.